# A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19

> **NCT06965751** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Melbourne** · enrollment: 32 (estimated)

## Conditions studied

- COVID-19 Infection

## Interventions

- **DRUG:** PDI204
- **OTHER:** 0.9 % saline

## Key facts

- **NCT ID:** NCT06965751
- **Lead sponsor:** University of Melbourne
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-06-27
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06965751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06965751, "A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06965751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*